It has been a while since there has been a landmark clinical trial on hypertension and I would like to bring the following important paper and accompanying Commentaries to your attention:
Vasileios is a special volunteer at Eunice Kennedy Shriver National Institute of Child Health and Human Development working in the lab of Dr. Stratakis. Read an interview with him to find out more about his scientific role models and goals.
The Council of the International Society of Hypertension (ISH) would like to invite scientists, research groups or National Societies of Hypertension to host the ISH Biennial Scientific Meeting in 2022.
Spotlight on the ISH New Investigator Programme, AHA Hypertension Council Scientific Sessions, September 2015
In September, the ISH New Investigator Committee (NIC) worked alongside the Trainee Advocacy Committee of the American Heart Association (AHA) Hypertension Council to build a New Investigator-centered programme. The programme continued to grow a longstanding relationship between the two committees and featured poster and oral communication sessions, awards and social interactions. The programme was a huge success with the largest participation of any ISH-sponsored symposia and was well received by all participants. Here we present three perspectives on the programme from members of the ISH New Investigator Committee Working Groups.
The September 2015 issue of ISH Hypertension News is now available. This includes a six part Hot off the press section, commissioned reports on (1) Hypertension in pregnancy (2) Statins and Myalgia: Fact or Fiction? (3) Pulmonary Hypertension (4) Biochemical Testing for Non-Adherence to Antihypertensive Medications, a focus on Professor Enrico Agabiti Rosei's excellent group in Brescia, Italy and much more. A full list of the newsletter contents follows.
New ASH-ISH Hypertension Guidelines Offer Practical, Clinical Information for Doctor and Patient Around the Globe
The ASH-ISH guidelines have been written to provide a straightforward approach to managing hypertension in the community, for practitioners in low and middle-income countries as well as developed countries.
You are viewing articles tagged with "yusuf".
Dr. Salim Yusuf, Ontario, Canada has headed up clinical trials in cardiovascular disease that have involved more than 80 countries around the world. He has truly international credentials and the Society was delighted to award him an Honorary Membership at its last Scientific Meeting.
Read More 12/05/2013